Li‐Bin Pan
Impact in
- Biological Psychiatry top 2%
- Tryptophan and brain disorders
- Pharmacology top 2%
- Berberine and alkaloids research
- Pharmacological Effects of Natural Compounds
Papers in
-
- Gut microbiota and health 13
- Ginseng Biological Effects and Applications 7
- Natural product bioactivities and synthesis 2
-
- Berberine and alkaloids research 7
- Alkaloids: synthesis and pharmacology 4
- Cannabis and Cannabinoid Research 3
- Co-authors
- Jian‐Dong Jiang (11 shared papers)Shurong Ma (15 shared papers)Ran Peng (12 shared papers)Hang Yu (17 shared papers)Zhenxiong Zhao (6 shared papers)Jinbo Yu (6 shared papers)Pei Han (5 shared papers)Jie Fu (3 shared papers)
- Journals
- Acta Pharmaceutica Sinica B (5 papers)Molecules (4 papers)Frontiers in Pharmacology (3 papers)Journal of Oral Microbiology (2 papers)Signal Transduction and Targeted Therapy (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Li‐Bin Pan
30 papers receiving 1.2k citations
Li‐Bin Pan's Hit Papers
Peers
Comparison fields: 5 of 103
- Biological Psychiatry 158
- Pharmacology 155
- Nephrology 107
- Complementary and alternative medicine 79
- Pharmacology 157
Countries citing papers authored by Li‐Bin Pan
This map shows the geographic impact of Li‐Bin Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li‐Bin Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li‐Bin Pan more than expected).
Fields of papers citing papers by Li‐Bin Pan
This network shows the impact of papers produced by Li‐Bin Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li‐Bin Pan. The network helps show where Li‐Bin Pan may publish in the future.
Co-authors
The 25 scholars most cited alongside Li‐Bin Pan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson’s disease by regulating gut microbiota Hit paper breakdown → | 2021 | 253 |
| 2 | 2019 | 153 | |
| 3 | Berberine treats atherosclerosis via a vitamine-like effect down-regulating Choline-TMA-TMAO production pathway in gut microbiota Hit paper breakdown → | 2022 | 131 |
| 4 | 2018 | 109 | |
| 5 | 2022 | 98 | |
| 6 | 2019 | 81 | |
| 7 | 2022 | 53 | |
| 8 | 2020 | 41 | |
| 9 | 2018 | 33 | |
| 10 | 2022 | 29 | |
| 11 | 2023 | 25 | |
| 12 | 2019 | 25 | |
| 13 | 2024 | 22 | |
| 14 | 2021 | 21 | |
| 15 | 2022 | 20 | |
| 16 | 2021 | 14 | |
| 17 | 2022 | 12 | |
| 18 | 2024 | 11 | |
| 19 | 2020 | 11 | |
| 20 | 2023 | 7 |
About Li‐Bin Pan
Li‐Bin Pan is a scholar working on Molecular Biology, Pharmacology, Pharmacology, Biological Psychiatry and Oncology, having authored 31 papers that have together received 1.2k indexed citations. Recurring topics across this work include Gut microbiota and health (13 papers), Berberine and alkaloids research (7 papers), Ginseng Biological Effects and Applications (7 papers), Tryptophan and brain disorders (4 papers), Alkaloids: synthesis and pharmacology (4 papers), Cannabis and Cannabinoid Research (3 papers), Gout, Hyperuricemia, Uric Acid (2 papers) and Natural product bioactivities and synthesis (2 papers). The work is most often cited by research in Biological Psychiatry (158 citations), Pharmacology (155 citations), Nephrology (107 citations), Complementary and alternative medicine (79 citations) and Pharmacology (157 citations). Li‐Bin Pan has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Jian‐Dong Jiang, Shurong Ma, Ran Peng, Hang Yu, Zhenxiong Zhao, Jinbo Yu, Pei Han, Jie Fu, Zhengwei Zhang and Zhengwei Zhang. Their work appears in journals such as Acta Pharmaceutica Sinica B, Molecules, Frontiers in Pharmacology, Journal of Oral Microbiology and Signal Transduction and Targeted Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.